ciclosporin and corticosteroid

Phase 2Small molecule

ciclosporin and corticosteroid is one of 12 small molecule programs targeting Idiopathic Inflammatory Myopathy. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Idiopathic Inflammatory MyopathyActive, not recruiting

Idiopathic Inflammatory MyopathyPhase 2

Active, not recruiting

Competition

Competitive Landscape

19 competitors in Idiopathic Inflammatory Myopathy

#DrugCompanyPhaseTrials

Orencia

Bristol-Myers Squibb

Phase 3

1 2

Vyvgart

Argenx

Phase 3

1 3

Fabhalta

Medrol

1 5

Interleukin 2

EEssen Biotech

Phase 2

2 6

Mesnex

BBaxter Healthcare Corporation

Phase 1

1 7

Cytoxan

BBaxter Healthcare Corporation

Phase 1

1 8

Rituxan

Pfizer

Phase 1

1 9

GC012F

GGracell Biotechnologies (Shanghai) Co., Ltd.

Phase 1

1 10

G-CSF

AArog Pharmaceuticals, Inc.

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Idiopathic Inflammatory Myopathy1 trial

Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy

Unknown status·PPeking University People's Hospital·Phase 2·NCT04237987·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for ciclosporin and corticosteroid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ciclosporin and corticosteroid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ciclosporin and corticosteroid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Peking University People's Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: PPeking University People's Hospital

ciclosporin and corticosteroid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Idiopathic Inflammatory Myopathy1 trial

References

Drug Info

Quick Facts

Related News